Drugs / Anti-pseudomonas IgY
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00633191 | Nov 2003 → Dec 2012 | Pseudomonas aeruginosa infectious disease, cystic fibrosis | Immunsystem AB | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-pseudomonas IgY | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00633191 ↗ |
| Modality | Protein / enzyme biologic | “specific avian antibodies against Pseudomonas aeruginosa” NCT00633191 ↗ |
| Route | Other | “Gargle (solution)” NCT00633191 ↗ |